Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema

PURPOSE: To evaluate the changes in visual acuity (VA) and central macular thickness (CMT) after intravitreal dexamethasone (IVD) implantation in intravitreal bevacizumab (IVB) treatment-resistant cases with pseudophakic cystoid macular edema (PCME). METHODS: This study included 10 PCME cases who un...

Descripción completa

Detalles Bibliográficos
Autores principales: Altintas, Ayse Gul Kocak, Ilhan, Cagri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557797/
https://www.ncbi.nlm.nih.gov/pubmed/31179657
http://dx.doi.org/10.3341/kjo.2018.0106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557797/
https://www.ncbi.nlm.nih.gov/pubmed/31179657
http://dx.doi.org/10.3341/kjo.2018.0106

Ejemplares similares